written by reader Miracle Mist

by ssanford | June 26, 2018 1:09 pm

Lindzon is touting this biotech stoke that is a spray to cure a sometimes deadly disease. FDA[1] has put it on the fast track. What is the stock?

Endnotes:
  1. FDA: https://www.stockgumshoe.com/tag/fda/

Source URL: https://www.stockgumshoe.com/2018/06/microblog-miracle-mist/


7 responses to “written by reader Miracle Mist”

  1. James Lee says:

    I could be complete wrong on this, but it sounds like Insys (INSY). Very beat-up MMJ stock that had some marketing misdeeds associated with it’s fentanyl drug. Meanwhile, they have a CBD mist in the pipeline. It is rare to see this kind of value with this kind of upside. Judge for yourself… https://globenewswire.com/news-release/2018/03/02/1414148/0/en/INSYS-Therapeutics-Initiates-Phase-3-Clinical-Trial-of-Cannabidiol-CBD-Oral-Solution-for-Treatment-of-Infantile-Spasms.html

  2. joeworld says:

    I think it’s Depression, and the stock may be a household name like Johnson & Johnson…

  3. Earl Finch says:

    Thoughts on VTGN Vistagen working on Esketamine for depression. JNJ is front runner with their subsidiary company.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.